HI
JAZZ icon

HBK Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

HBK Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-61,900
Closed -$7.67M – 1200
2018
Q4 		$7.67M Buy
61,900
+12,400
+25% +$1.84M 0.08% 192
2018
Q3 		$8.32M Buy
+49,500
New +$8.51M 0.07% 182
2018
Q2 		– Sell
-6,893
Closed -$1.04M – 1089
2018
Q1 		$1.04M Sell
6,893
-15,707
-70% -$2.3M 0.01% 612
2017
Q4 		$3.04M Buy
22,600
+13,900
+160% +$1.93M 0.02% 356
2017
Q3 		$1.27M Sell
8,700
-3,600
-29% -$544K 0.01% 564
2017
Q2 		$1.91M Buy
+12,300
New +$1.88M 0.01% 421
2017
Q1 		– Sell
-126,453
Closed -$13.8M – 746
2016
Q4 		$13.8M Buy
126,453
+59,753
+90% +$6.66M 0.13% 121
2016
Q3 		$8.1M Buy
66,700
+43,413
+186% +$5.85M 0.07% 171
2016
Q2 		$3.29M Buy
23,287
+15,784
+210% +$2.33M 0.02% 311
2016
Q1 		$980K Buy
+7,503
New +$934K 0.01% 593
2015
Q4 		– Sell
-10,500
Closed -$1.4M – 1041
2015
Q3 		$1.4M Buy
10,500
+2,400
+30% +$413K 0.01% 506
2015
Q2 		$1.43M Buy
+8,100
New +$1.45M 0.01% 489
2014
Q4 		– Sell
-47,877
Closed -$7.69M – 1052
2014
Q3 		$7.69M Buy
47,877
+20,077
+72% +$3.09M 0.12% 143
2014
Q2 		$4.09M Sell
27,800
-94,300
-77% -$13.1M 0.08% 212
2014
Q1 		$16.9M Buy
+122,100
New +$18.4M 0.31% 55
2013
Q4 		– Sell
-13,515
Closed -$1.24M – 950
2013
Q3 		$1.24M Buy
13,515
+7,515
+125% +$606K 0.02% 408
2013
Q2 		$412K Buy
+6,000
New +$367K 0.01% 615

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments's JAZZ Position: Q1 2019 in Review

HBK Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2019, closing a stake of 61,900 shares — an estimated $7.67M sold.

HBK Investments first reported a position in JAZZ in Q2 2013 and held it in 17 quarters. The position peaked at $16.9M in Q1 2014. 427 funds tracked by Wall St. Rank hold JAZZ as of Q1 2019.

  • HBK Investments reported no remaining Jazz Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • HBK Investments sold 61,900 Jazz Pharmaceuticals shares in Q1 2019, an estimated $7.67M.
  • HBK Investments first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • HBK Investments's Jazz Pharmaceuticals position peaked at $16.9M in Q1 2014.
  • 427 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2019.

Based on HBK Investments's 13F filing for Q1 2019, filed 15 May 2019.